Madhavan Nallani

Company: ACM Biosciences

Job title: Founder & Chief Executive Officer

Seminars:

Thermostable mRNA Vaccines using Hybrid Polymer-Lipid Nanoparticles 11:30 am

Presenting a polymer-based nanoparticles for vaccines and therapeutics Highlighting 12-month stability data of liquid formulations at 2 – 80°C and improvements related to anti-PEG antibodies and response durability Outlining a CEPI funded rabies mRNA vaccine programRead more

day: Day Two